Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,411,033
-
Total 13F shares
-
57,466,718
-
Share change
-
-145,632
-
Total reported value
-
$326,999,436
-
Put/Call ratio
-
5.4%
-
Price per share
-
$5.69
-
Number of holders
-
115
-
Value change
-
-$1,731,457
-
Number of buys
-
64
-
Number of sells
-
47
Institutional Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q3 2022
As of 30 Sep 2022 Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) had 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 57,466,718 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, EcoR1 Capital, LLC, FEDERATED HERMES, INC., Bain Capital Life Sciences Investors, LLC, STATE STREET CORP, Cormorant Asset Management, LP, GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This table shows 115 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.